Avid Bioservices Inc (CDMO)

[itsabouttime]

Daily Quint

January 18, 2017 ?James Williams

Eqis Capital Management Inc. lowered its position in shares of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) by 2.2% during the third quarter, Holdings Channel reports. The institutional investor owned 1,475,396 shares of the bio-pharmaceutical company’s stock after selling 32,956 shares during the period. Eqis Capital Management Inc. owned approximately 0.61% of Peregrine Pharmaceuticals worth $634,000 as of its most recent SEC filing.


Other hedge funds and other institutional investors have also modified their holdings of the company. Jacobs Levy Equity Management Inc. increased its position in shares of Peregrine Pharmaceuticals by 173.7% in the first quarter. Jacobs Levy Equity Management Inc. now owns 1,009,400 shares of the biopharmaceutical company’s stock worth $424,000 after buying an additional 640,570 shares in the last quarter. Laurion Capital Management LP purchased a new position in shares of Peregrine Pharmaceuticals during the second quarter worth approximately $242,000. Finally, Paloma Partners Management Co purchased a new position in shares of Peregrine Pharmaceuticals during the second quarter worth approximately $311,000. Institutional investors and hedge funds own 13.58% of the company’s stock.